Review Connects Gut Microbiome Imbalance to Psoriasis Development
Summary
A new scientific review links psoriasis, an autoimmune skin disease, to gut microbiome imbalance (dysbiosis). The authors suggest that a compromised intestinal barrier, or "leaky gut," allows inflammatory bacterial products to enter the bloodstream, triggering systemic immune responses that manifest as skin inflammation. Additionally, specific microbial byproducts can either exacerbate or suppress this inflammation, directly affecting psoriasis severity. The review concludes that the gut microbiome acts as a central regulatory hub in psoriasis development, highlighting gut health as a crucial factor in managing the disease.
Why This Is Interesting
Traditionally, psoriasis has been treated as a disease of the skin and immune system, with treatments often focused on topical creams or systemic immune suppressants. This review highlights a significant shift in thinking, reframing psoriasis as a systemic condition deeply connected to gut health. This 'gut-skin axis' concept moves the focus beyond managing symptoms to addressing a potential root cause. For individuals with psoriasis, this is empowering. It suggests that lifestyle interventions aimed at improving gut health—such as dietary changes, probiotics, or prebiotics—could become a key part of a holistic management plan. It provides a scientific rationale for the connection many patients feel between their diet, their gut, and their skin health.
Published in Frontiers in Immunology
"Review Connects Gut Microbiome Imbalance to Psoriasis Development." Frontiers in Immunology, 23 Mar. 2026, pubmed.ncbi.nlm.nih.gov/41869364/.